Literature DB >> 12763315

Specific recognition of primer tRNA Lys 3 by HIV-1 nucleocapsid protein: involvement of the zinc fingers and the N-terminal basic extension.

Carine Tisné1, Bernard P Roques, Frédéric Dardel.   

Abstract

Reverse transcription of HIV-1 viral RNA uses human tRNA(Lys)(3) as a primer. We have previously characterised the structural aspects of the tRNA(Lys)(3) interaction by NMR. In HIV-1 virions, the nucleocapsid protein NCp7 contains two zinc fingers flanked by basic residues. Using NMR, the respective role of the N-terminal residues and the zinc fingers in the interaction with tRNA(Lys)(3)/NCp7 was investigated by studying the tRNA(Lys)(3) and tRNA(Lys)(3)/NCp7 complexes. The N-terminal basic residues do not change the footprint of NC on tRNA(Lys)(3)/Cys(23)NCp7 but strengthen the binding whereas the mutation of the zinc-binding histidine at position 23 that was shown to result in non-infectious particles prevents the interaction with the first bases of the acceptor stem.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763315     DOI: 10.1016/s0300-9084(03)00034-8

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  9 in total

1.  Vasa genes: emerging roles in the germ line and in multipotent cells.

Authors:  Eric A Gustafson; Gary M Wessel
Journal:  Bioessays       Date:  2010-07       Impact factor: 4.345

2.  Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein.

Authors:  Mattia Mori; Maria Chiara Dasso Lang; Francesco Saladini; Nastasja Palombi; Lesia Kovalenko; Davide De Forni; Barbara Poddesu; Laura Friggeri; Alessia Giannini; Savina Malancona; Vincenzo Summa; Maurizio Zazzi; Yves Mely; Maurizio Botta
Journal:  ACS Med Chem Lett       Date:  2018-12-07       Impact factor: 4.345

3.  Simulation study of the ability of a computationally-designed peptide to recognize target tRNALys3 and other decoy tRNAs.

Authors:  Xingqing Xiao; Binwu Zhao; Paul F Agris; Carol K Hall
Journal:  Protein Sci       Date:  2016-10-07       Impact factor: 6.725

4.  Functional recognition of the modified human tRNALys3(UUU) anticodon domain by HIV's nucleocapsid protein and a peptide mimic.

Authors:  William D Graham; Lise Barley-Maloney; Caren J Stark; Amarpreet Kaur; Christina Stolarchuk; Khrystyna Stolyarchuk; Brian Sproat; Grazyna Leszczynska; Andrzej Malkiewicz; Nedal Safwat; Piotr Mucha; Richard Guenther; Paul F Agris
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

5.  Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes.

Authors:  Jennifer T Miller; Anastasia Khvorova; Stephen A Scaringe; Stuart F J Le Grice
Journal:  Nucleic Acids Res       Date:  2004-09-01       Impact factor: 16.971

6.  Initiation of HIV Reverse Transcription.

Authors:  Catherine Isel; Chantal Ehresmann; Roland Marquet
Journal:  Viruses       Date:  2010-01-18       Impact factor: 5.818

7.  Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins.

Authors:  Margareta Cruceanu; Maria A Urbaneja; Catherine V Hixson; Donald G Johnson; Siddhartha A Datta; Matthew J Fivash; Andrew G Stephen; Robert J Fisher; Robert J Gorelick; Jose R Casas-Finet; Alan Rein; Ioulia Rouzina; Mark C Williams
Journal:  Nucleic Acids Res       Date:  2006-01-30       Impact factor: 16.971

8.  Dynamics of linker residues modulate the nucleic acid binding properties of the HIV-1 nucleocapsid protein zinc fingers.

Authors:  Loussiné Zargarian; Carine Tisné; Pierre Barraud; Xiaoqian Xu; Nelly Morellet; Brigitte René; Yves Mély; Philippe Fossé; Olivier Mauffret
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

Review 9.  Comparative nucleic acid chaperone properties of the nucleocapsid protein NCp7 and Tat protein of HIV-1.

Authors:  Julien Godet; Christian Boudier; Nicolas Humbert; Roland Ivanyi-Nagy; Jean-Luc Darlix; Yves Mély
Journal:  Virus Res       Date:  2012-06-26       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.